ストックスクリーナーアプリを入手
42.52
1.75%
0.6996
前日終値:
$41.82
開ける：
$42.23
24時間の取引高:
87,945
Relative Volume:
0.17
時価総額：
$1.92B
収益：
$1.08B
当期純損益:
$-20.76M
株価収益率:
-55.22
EPS:
-0.77
ネットキャッシュフロー:
$151.63M
1週間 パフォーマンス:
-8.68%
1か月 パフォーマンス:
+5.15%
6か月 パフォーマンス:
+33.35%
1年 パフォーマンス:
+31.05%
1日の値動き範囲:
$42.08
$42.80
1週間の範囲:
$41.27
$47.11
52週間の値動き範囲:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
OMCL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| OMCL | 42.58 | 1.92B | 1.08B | -20.76M | 151.63M | -0.77 |
| VEEV | 213.48 | 33.92B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 69.22 | 11.55B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 49.68 | 9.32B | 493.63M | 160.55M | 162.20M | 0.55 |
| TEM | 54.96 | 9.04B | 640.44M | -743.28M | -206.93M | 0.00 |
| HQY | 103.11 | 8.87B | 1.10B | 105.67M | -197.98M | 0.1475 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-01-03 | 開始されました | Barclays | Underweight |
| 2023-11-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-11-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 繰り返されました | Wells Fargo | Underweight |
| 2023-08-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | アップグレード | The Benchmark Company | Hold → Buy |
| 2022-11-03 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 開始されました | BofA Securities | Buy |
| 2022-07-15 | 開始されました | SVB Leerink | Mkt Perform |
| 2021-12-06 | 再開されました | Wells Fargo | Overweight |
| 2021-06-09 | 開始されました | JP Morgan | Neutral |
| 2021-05-24 | 開始されました | BTIG Research | Buy |
| 2021-02-02 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 開始されました | Berenberg | Buy |
| 2020-12-03 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-02-07 | 繰り返されました | Dougherty & Company | Buy |
| 2019-11-21 | 繰り返されました | Dougherty & Company | Buy |
| 2019-07-26 | アップグレード | Craig Hallum | Hold → Buy |
| 2019-03-07 | 繰り返されました | Dougherty & Company | Buy |
| 2018-06-29 | 再開されました | The Benchmark Company | Buy |
| 2017-09-05 | 繰り返されました | The Benchmark Company | Buy |
| 2017-07-28 | 繰り返されました | Dougherty & Company | Buy |
| 2017-04-21 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 開始されました | Dougherty & Company | Buy |
| 2016-12-06 | 繰り返されました | The Benchmark Company | Buy |
| 2016-07-07 | 繰り返されました | FBR Capital | Outperform |
| 2016-03-21 | 繰り返されました | Topeka Capital Markets | Buy |
| 2016-01-07 | 開始されました | The Benchmark Company | Buy |
| 2015-11-16 | 繰り返されました | Topeka Capital Markets | Buy |
| 2015-10-30 | 繰り返されました | FBR Capital | Outperform |
| 2015-09-28 | アップグレード | Sidoti | Neutral → Buy |
| 2015-07-31 | 繰り返されました | Topeka Capital Markets | Buy |
すべてを表示
Omnicell Inc (OMCL) 最新ニュース
Royce & Associates LP Purchases Shares of 18,597 Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell prices $150M debt offering via issuance of convertible senior notes - MSN
Here's Why You Should Add OMCL Stock to Your Portfolio Now - MSN
Robotic Dentistry Market: Trade Analysis and Growth - openPR
Omnicell Prices $150M Convertible Notes at 1% Interest, Due 2029 | OMCL Stock News - StockTitan
Omnicell (NASDAQ:OMCL) Shares Gap DownHere's What Happened - MarketBeat
Medication Management Systems Market Will Accelerate Rapidly - openPR
Principal Financial Group Inc. Has $9.99 Million Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes - BioSpace
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases New Shares in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell (NASDAQ:OMCL) Downgraded to "Hold" Rating by StockNews.com - MarketBeat
Victory Capital Management Inc. Raises Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Better Than Expected Q2 Earnings Prompt Buying Interest In Omnicell - RTTNews
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Omnicell Inc. (OMCL) Quarterly 10-Q Report - Quartzy
New Horizons in Medication Management Tools Market Exploring - openPR
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock - MSN
Omnicell, Inc. (NASDAQ:OMCL) Q3 2024 Earnings Call Transcript - MSN
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave By Investing.com - Investing.com Australia
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave - Investing.com India
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? - Benzinga
Omnicell Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next - Simply Wall St
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised - MSN
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out? - MSN
Rice Hall James & Associates LLC Invests $2.72 Million in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell Appoints Nnamdi Njoku as Executive Vice President and C - GuruFocus.com
Omnicell cut to neutral by BofA, lack of visibility into growth cited - MSN
Omnicell Q3 Earnings: Look At The Growth Segment (NASDAQ:OMCL) - Seeking Alpha
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL) - Yahoo Finance
What 5 Analyst Ratings Have To Say About Omnicell - Benzinga
Omnicell (NASDAQ:OMCL) Price Target Raised to $58.00 - MarketBeat
Omnicell stock hits 52-week high at $45.85 amid market rally - Investing.com Australia
Omnicell's (OMCL) Neutral Rating Reaffirmed at Bank of America - MarketBeat
42,461 Shares in Omnicell, Inc. (NASDAQ:OMCL) Acquired by Roubaix Capital LLC - MarketBeat
Omnicell stock downgraded at BofA on growth visibility concerns - Investing.com
Omnicell Inc (OMCL) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Omnicell stock downgraded at BofA on growth visibility concerns By Investing.com - Investing.com UK
Omnicell Inc (OMCL) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges with Strategic Innovations - GuruFocus.com
Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)? - Simply Wall St
Omnicell Inc (OMCL) Q3 2024 Earnings: EPS at $0.19 Beats Estimat - GuruFocus.com
Omnicell Reports Strong Q3 2024 Financial Results - TipRanks
Top Medical Stock Breaks Out After Obliterating Profit Views - Investor's Business Daily
Omnicell stock hits 52-week high at $45.85 amid market rally By Investing.com - Investing.com South Africa
Omnicell soars after bullish quarterly report, outlook - XM
Omnicell (OMCL) Beats Q3 Earnings and Revenue Estimates - MSN
Omnicell Q3 2024 Earnings Preview - MSN
Omnicell (NASDAQ:OMCL) Reaches New 52-Week HighWhat's Next? - MarketBeat
Omnicell earnings beat by $0.14, revenue topped estimates - Investing.com Canada
Omnicell Inc (OMCL) 財務データ
収益
当期純利益
現金流量
EPS
0.22%
0.05%
大文字化:
|
ボリューム (24 時間):